Clinical Trials in Philadelphia

Showing 10561-10580 of 20,904 trials

Deep Phenotyping in Patients With ALS

NCT02819765

This study aims to establish a biorepository and phenotyping database to investigate longitudinal changes in ALS subjects. Blood, including DNA and RNA, cerebrospinal fluid (CSF) and electrophysiologic measures will be collected every 6 months over 1 and a half years. The database and specimen repository will be made available to ALS researchers on a merit basis.

ALSMotor Neuron Disease

Barrow Neurological Institute32 participantsStarted Feb 2017

Phoenix, Arizona, United States • Grand Rapids, Michigan, United States • New York, New York, United States +4 more locations

TERMINATEDPhase 3< 1 mile

T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802)

NCT04128319

The study is designed as an open-label, single arm Phase III, multicenter trial to evaluate the efficacy and safety of T-Guard treatment in patients with Steroid-Refractory acute Graft versus Host Disease (SR-aGVHD).

Steroid-Refractory Acute Graft Versus Host Disease

Xenikos3 participantsStarted Nov 2019

Duarte, California, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +21 more locations

Deep Phenotyping in Patients With ALS

T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802)

Find Trials by Condition in Philadelphia

Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation

Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C

Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

Vinflunine in Hormone Refractory Prostate Cancer (HRPC)

5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer

Study of CAD-9303 in Subjects With Schizophrenia

Comparative Bioavailability of Risperidone

A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease

Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma

Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes

Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

Randomized Endo-Vein Graft Prospective

Restore EF Observational Study

Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)

Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study)

PREMOD2 With Near Infrared Spectroscopy Sub-study